Subscribe To Our Free Newsletter |
Q4 Results Preview: Lupin may see strong topline, bottomline growth
Indian pharmaceutical major Lupin is set to witness a strong financial earnings on a year-on-year (Y-o-Y) basis for the fourth quarter of the financial year 2023-24 (Q4FY23)